Published in Cytometry on March 01, 1985
The combination of yondelis and cisplatin is synergistic against human tumor xenografts. Eur J Cancer (2003) 1.63
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent. Eur J Cancer Clin Oncol (1987) 1.08
Mitozolomide activity on human cancer cells in vitro. Br J Cancer (1986) 1.00
Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA. Oncogene (2011) 0.96
Cell cycle effects of gemcitabine. Int J Cancer (2001) 0.95
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine. Br J Cancer (2002) 0.91
Characterization of cyclin B1 expression in human cancer cell lines by a new three-parameter BrdUrd/cyclin B1/DNA analysis. Cytometry (1998) 0.88
Microcomputer experience in analysis of flow cytometric DNA distributions. Comput Programs Biomed (1985) 0.86
Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by taxol. Cytometry (1999) 0.86
Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting anti-neoplastic agents. Int J Cancer (1993) 0.86
Dynamics of anthracyclines/DNA interaction: a laser time-resolved fluorescence study. Photochem Photobiol (1988) 0.84
DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies. Br J Cancer (1985) 0.83
Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach. Cell Prolif (2007) 0.83
Intracellular doxorubicin concentrations and drug-induced DNA damage in a human colon adenocarcinoma cell line and in a drug-resistant subline. Biochem Pharmacol (1988) 0.83
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma. Nanotechnology (2014) 0.83
Desynchronization rate in cell populations: mathematical modeling and experimental data. J Theor Biol (2001) 0.83
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients. Leuk Res (1991) 0.81
A mathematical model of the effect of aging on bone marrow cells colonizing the thymus. Mech Ageing Dev (1993) 0.81
DNA damage, cytotoxic effect and cell-cycle perturbation of Hoechst 33342 on L1210 cells in vitro. Cytometry (1988) 0.81
Comparison of histone variant synthesis in human lymphocytic leukemia cells and in normal lymphocytes. Cancer Res (1988) 0.81
Quarterly report on hospital financial status. Hospitals (1978) 0.80
Quality control study of the Italian Group of Cytometry on flow cytometry DNA content measurements: II. Factors affecting inter- and intralaboratory variability. Cytometry (1997) 0.80
Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents. Int J Cancer (1997) 0.79
Flow cytometric analysis of DNA content in human ovarian cancers. Br J Cancer (1989) 0.79
Matching of group velocities by spatial walk-off in collinear three-wave interaction with tilted pulses. Opt Lett (1996) 0.79
Study of propidium iodide binding to DNA in intact cells by flow cytometry. Cell Biophys (1990) 0.78
Effects of laser irradiation on hematoporphyrin-treated normal and transformed thyroid cells in culture. Cancer Res (1983) 0.78
The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing molecule. Cancer Chemother Pharmacol (1999) 0.78
Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma. Cancer Chemother Pharmacol (1983) 0.78
Atenolol-induced regulation of leukocyte beta 2-adrenoceptors in hypertension. Pharmacology (1984) 0.77
Studies on curcumin and curcuminoids. XLVI. Photophysical properties of dimethoxycurcumin and bis-dehydroxycurcumin. J Fluoresc (2011) 0.77
Cell loss and the concept of potential doubling time. Cytometry (1997) 0.77
Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders. Biol Psychiatry (1991) 0.76
Acebutolol-induced decrease of mononuclear leukocyte beta-adrenoceptors in hypertension. Pharmacology (1985) 0.76
Effects of cholinergic muscarinic antagonist pirenzepine on GH response to GHRH 1-40 in patients with anorexia nervosa. Endocrinol Exp (1990) 0.76
Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine. Ann Oncol (1994) 0.76
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications. Drugs (1995) 0.76
Time- and dose-dependence of DNA fragmentation induced by anticancer agents: a flow cytometric study. Eur J Histochem (1997) 0.75
Laser time-resolved fluorescence study of the interaction between anthracyclines and cardiolipin. J Photochem Photobiol B (1989) 0.75
Characterization of transformed cell lines evolving from a normal C3H line. Exp Cell Biol (1988) 0.75
Organ procurement for multivisceral abdominal transplantation in the pig. Transplant Proc (1988) 0.75
Quarterly report on hospital financial status. Hospitals (1977) 0.75
[Effectiveness of treatment with beta-blocking agents and diuretics in fixed combination, in aged hypertensive patients]. G Ital Cardiol (1980) 0.75
Representing cell cycle data. Cytometry (1986) 0.75
Apparent free cortisol concentrations in patients with anorexia nervosa at different stages of the disease. J Endocrinol Invest (1984) 0.75
[First experience with hepatic transplant in children at the Ospedale Maggiore Policlinico of Milan]. Minerva Anestesiol (1990) 0.75
Biochemical, morphological and flow-cytometric evaluation of the effects of hexachlorobenzene on rat liver. Cell Biol Toxicol (1990) 0.75
Employee wages and benefits. Hospitals (1977) 0.75
The use of artificial ligaments in anterior cruciate ligament reconstruction. Ital J Orthop Traumatol (1990) 0.75
From flow cytometric BrdUrd data to cell population growth and doubling time. Cytometry (1997) 0.75
Dose estimate of exposure to radioisotopes in molecular and cellular biology. J Radiol Prot (1999) 0.75
[Orthotopic transplant of the liver 15 years later. Experimental study]. Minerva Chir (1984) 0.75
Inhibition of human platelet aggregation by stable analogs of prostacyclin. Pharmacol Res Commun (1977) 0.75
Histone H1(0) is synthesized by human lymphocytic leukemia cells but not by normal lymphocytes. Blood (1987) 0.75
Heterotopic liver allograft in acute hepatic failure in pigs. Int Surg (1986) 0.75
Combination of the new minor groove alkylator tallimustine and melphalan. Eur J Cancer (1997) 0.75
[6-Methyl-19-nor-pregnenes. I. Splitting of the tetrahydrofuranic ring in 6 alpha-methyl-6 beta, 19-oxides]. Farmaco Sci (1974) 0.75
Solar UV radiation: differential effectiveness of UVB subcomponents in causing cell death, micronucleus induction and delayed expression of heritable damage in human hybrid cells. Int J Radiat Biol (2001) 0.75
Intracellular drug concentration and DNA damage in human childhood leukemic cells exposed to doxorubicin. Biochem Pharmacol (1988) 0.75
Hematoporphyrin derivative photoradiation therapy in murine solid tumors. Cancer Lett (1983) 0.75
Real-time holograms generated by second-harmonic cross correlation of object and reference optical wave fields. Opt Lett (2000) 0.75
Genotoxic damage induced by doxorubicin in two human melanoma cell lines. Cytotechnology (1987) 0.75
Fluorescence lifetimes of angular furocoumarins. Photochem Photobiol (1987) 0.75
Photodynamic therapy in vitro and in vivo with hematoporphyrin derivative and laser light. Neoplasma (1987) 0.75
[3 cases of cleidocranial dysostosis]. Chir Organi Mov (1990) 0.75
Hematoporphyrin derivative photochemotherapy of spontaneous animal tumors: clinical results with optimized drug dose. Cancer Lett (1984) 0.75
Quarterly report on hospital financial status. Hospitals (1977) 0.75
Visible pulses of 100 fs and 100 μJ from an upconverted parametric generator. Appl Opt (1996) 0.75
[Heterotopic liver transplant for irreversible hepatic necrosis. An experimental study in the pig]. Minerva Chir (1986) 0.75
Failure of glucose infusion to suppress the exaggerated GH response to GHRH in patients with anorexia nervosa. Biol Psychiatry (1990) 0.75
Quarterly report on hospital financial status. Hospitals (1978) 0.75
[Anthracycline resistance: cytofluorometric study on infantile lymphoblastic leukemia]. Medicina (Firenze) (1990) 0.75
A double-blind comparative study of ketanserin with atenolol in essential hypertension. Drugs Exp Clin Res (1989) 0.75
Corticotrophin-releasing hormone does not inhibit growth hormone-releasing hormone-induced release of growth hormone in control subjects but is effective in patients with eating disorders. J Endocrinol (1994) 0.75
Cytologic and flow cytometric DNA analysis of multinucleated tumor cells and derived microcells. Anal Quant Cytol Histol (1989) 0.75
Hospital indicators: quarterly report on hospital financial status. Hospitals (1979) 0.75
Recent developments in imaging diagnosis in fractures of the acetabulum: the role of CAT and tridimensional reconstruction. Ital J Orthop Traumatol (1990) 0.75
Group-velocity control in the mixing of three noncollinear phase-matched waves. Appl Opt (1998) 0.75
[Lysine acetylsalicylate in the control of postoperative pain in surgery of the upper abdomen]. Minerva Anestesiol (1981) 0.75
Flow-cytometric measurement of histone H1o in human cells. Anal Biochem (1993) 0.75
[Cytofluorometry with pulsed and tunable lasers: a new method for molecular cytology]. Riv Istochim Norm Patol (1975) 0.75
Flow cytometric detection of glutathione S-transferase isoenzymes by quantitative immunofluorescence under nonsaturating conditions. Cytometry (1995) 0.75
Trends in personnel expenses. Hospitals (1978) 0.75
Latest utilization statistics. Hospitals (1977) 0.75